Electrochemical Characterization of Escherichia coli Adaptive Response Protein AidB by Hamill, Michael J. et al.
Int. J. Mol. Sci. 2012, 13, 16899-16915; doi:10.3390/ijms131216899 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Article 
Electrochemical Characterization of Escherichia coli Adaptive 
Response Protein AidB 
Michael J. Hamill 
1,2
, Marco Jost 
2
, Cintyu Wong 
2,†
, Nicholas C. Bene 
1
,  
Catherine L. Drennan 
2,3,4,5
 and Sean J. Elliott 
1,
* 
1
 Department of Chemistry, Boston University, 590 Commonwealth Ave., Boston, MA 02215, USA; 
E-Mails: mike.j.hamill@gmail.com (M.J.H.); nchangbene@gmail.com (N.C.B.) 
2 
Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Ave., 
Cambridge, MA 02139, USA; E-Mails: mjost@mit.edu (M.J.); cdrennan@mit.edu (C.L.D.) 
3
 Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 
4
 Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge,  
MA 02139, USA 
5
 Center for Environmental Health, Massachusetts Institute of Technology, Cambridge,  
MA 02139, USA 
†
 Present address: Johnson & Johnson Pharmaceutical Research & Development,  
930 Route 202 South, Raritan, NJ 08869, USA; E-Mail: cintyu@gmail.com. 
* Author to whom correspondence should be addressed; E-Mail: elliott@bu.edu;  
Tel.: +1-617-358-2816; Fax: +1-617-353-6466.  
Received: 7 October 2012; in revised form: 26 November 2012 / Accepted: 3 December 2012 /  
Published: 11 December 2012 
 
Abstract: When exposed to known DNA-damaging alkylating agents, Escherichia coli 
cells increase production of four DNA repair enzymes: Ada, AlkA, AlkB, and AidB. The 
role of three enzymes (Ada, AlkA, and AlkB) in repairing DNA lesions has been well 
characterized, while the function of AidB is poorly understood. AidB has a distinct 
cofactor that is potentially related to the elusive role of AidB in adaptive response: a redox 
active flavin adenine dinucleotide (FAD). In this study, we report the thermodynamic 
redox properties of the AidB flavin for the first time, both for free protein and in the 
presence of potential substrates. We find that the midpoint reduction potential of the AidB 
flavin is within a biologically relevant window for redox chemistry at −181 mV, that AidB 
significantly stabilizes the flavin semiquinone, and that small molecule binding perturbs 
the observed reduction potential. Our electrochemical results combined with structural 
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analysis allow for fresh comparisons between AidB and the homologous acyl-coenzyme A 
dehydrogenase (ACAD) family of enzymes. AidB exhibits several discrepancies from 
ACADs that suggest a novel catalytic mechanism distinct from that of the ACAD  
family enzymes.  
Keywords: adaptive response; DNA repair; protein electrochemistry; acyl-coenzyme A 
dehydrogenase; flavin cofactor; reduction potential 
 
1. Introduction 
Escherichia coli adaptive response is a process initiated by the exposure of cells to low doses of 
DNA alkylating agents, which have mutagenic and cytotoxic effects on cells [1–3]. The adaptive 
response process refers to the up-regulation of four proteins, Ada, AlkA, AlkB, and AidB, that reduce 
the effects of alkylation on DNA [3,4]. Out of these four proteins, three have known roles in the 
adaptive response as enzymes that repair DNA lesions via a variety of mechanisms: Ada as a 
methyltransferase [5–8], AlkA as a glycosylase [9,10], and AlkB as a dioxygenase [11–15]. A 
complete understanding of the fourth protein, AidB, remains elusive. 
By sequence homology, AidB is similar to members of the acyl-coenzyme A dehydrogenase 
(ACAD) enzyme family [16], which contain a redox active flavin adenine dinucleotide (FAD) cofactor 
that catalyzes the α,β-dehydrogenation of acyl-coenzyme A (CoA) substrates (Scheme 1). AidB 
similarly contains a FAD cofactor and displays isovaleryl-coenzyme A dehydrogenase (IVD)  
activity [16,17]. This activity, however, is 1000-fold lower than that of known ACADs and therefore 
probably not biologically relevant to AidB function [16,17]. The observation of bound FAD, combined 
with evidence for DNA binding, led to the hypothesis that a flavin-dependent dehydrogenation 
reaction similar to reactions catalyzed by ACADs could be used to repair DNA lesions [17]. This 
model was superseded when the first crystal structure of AidB provided evidence that a direct reaction 
between the flavin and DNA is unlikely due to spatial constraints. Instead, based on crystal packing 
data it was proposed that AidB sheaths DNA by forming higher-ordered structures of tetramers, 
generating pores for DNA binding and resulting in steric protection [18]. In this model, flavin has a 
role protecting DNA via an unknown redox mechanism that deactivates harmful alkylating  
agents [18]. Significant in vivo evidence for AidB protection of DNA against the alkylating agents  
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), N-ethyl-N'-nitro-N-nitrosoguanidine, and methyl 
methanesulfonate (MMS) has recently been reported [19], although it has also been shown AidB does 
not directly react with MNNG [20]. Surprisingly, the DNA-binding domain of AidB is not required for 
protection activity, making a steric protection mechanism unlikely [19,21]. Rather, it is suggested  
that AidB uses its DNA-binding domain to preferentially localize to regions of DNA, so-called UP 
elements, found upstream of ribosomal RNA genes, tRNA genes, and DNA repair genes as a means to 
localize detoxification activity to these crucial genes [19]. 
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Scheme 1. Generic mechanism for dehydrogenation of a substrate by an acyl-coenzyme  
A dehydrogenase. 
 
A mechanism by which AidB prevents DNA damage by detoxifying alkylating agents has not been 
proposed. Since no activity besides that with isovaleryl-coenzyme A (IVCoA) has been reported,  
the role of bound flavin in AidB’s detoxification mechanism is unclear. In our previous work we 
demonstrated that flavin clearly plays a structural role in AidB by inducing formation of a  
tetramer [21]. This observation motivates a lingering question: does the AidB flavin also play a role in 
redox chemistry? This possibility was most recently studied by Mulrooney et al. who observed the 
reduction of AidB by E. coli flavodoxin (FldA), but at slow electron transfer rates that suggest it is not 
physiologically relevant [20]. 
To determine the possibility of an enzymatic flavin role, we extensively characterized the redox 
properties of AidB to place AidB in the context of known, specific flavin chemistries. Furthermore, we 
investigated the option of redox modulations caused by potential AidB substrates such as IVCoA or 
DNA, providing a comparison between AidB and the ACAD family of enzymes that have  
well-characterized and distinctive redox properties. Here we show for the first time that AidB is 
capable of mediating redox chemistries within a physiologically relevant window of reduction 
potential. In addition, the ability of AidB to generate a significant amount of flavin semiquinone 
suggests a role for AidB as a redox enzyme, but with chemistries distinct from that of the ACAD family. 
2. Results 
2.1. Determination of Reduction Potentials for AidB 
The reduction of AidB occurs in two resolvable phases (Figure 1). The first phase is the reduction 
of oxidized flavin (ox) to the distinct anionic semiquinone (sq) that has a characteristic absorbance 
maximum at lower wavelengths [22]. The absorbance maximum for the AidB anionic semiquinone  
is 365 nm (in agreement with 370 nm typically observed for anionic semiquinones in other  
flavoenzymes [23]), with an isosbestic point at 409 nm observed during the transition from the 
oxidized to the semiquinone species (Figure 1A). The second phase of reduction is the transition from 
the anionic semiquinone to fully reduced flavin (red). This phase is observed simultaneously with the 
reduction of phenosafranine (PS), indicative of similar reduction potentials (Figure 1B). Absorbance of 
AidB semiquinone at 406 nm during the second phase of reduction was used to monitor the transition 
from oxidized to reduced, and these data were plotted versus the reduction of PS as described in the 
experimental procedures. We determine a reduction potential of Em
sq/red
 = −258 ± 6 mV for the sq/red 
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couple, with a log plot slope of 1.96, indicative of comparing two-electron and one-electron processes 
for PS and AidB, respectively (Figure 2). 
Figure 1. Complete anaerobic reduction of AidB using the xanthine/xanthine oxidase 
method. (A) Representative spectra of the three redox states observed for AidB: oxidized 
(solid line), anionic semiquinone (dashed line), and reduced (dotted line); (B) Reduction of 
AidB in the presence of the redox dye PS (maximum absorbance at 520 nm), showing 
spectra collected every ~5 min. 
 
Figure 2. Simultaneous reduction of the AidB anionic semiquinone and PS. The visible 
absorbance spectra for the anionic semiquinone (monitored at 406 nm) and PS (monitored 
at 555 nm) decrease during their reduction. Inset: Plot of log [ox]/[red] for PS vs.  
log [sq]/[red] for AidB, used to calculate the midpoint potential with respect to the 
reference value of PS (−283 mV, pH 8). 
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To analyze the first step of reduction, we measured the maximum amount of semiquinone 
intermediate formed during the experiment (Figure 3). This fraction corresponds to the semiquinone 
formation constant (Ksq, Equation 1) according to Equation 2 as derived by Clark [24]. Ksq reflects the 
difference in midpoint potentials of the two single-electron redox transitions as shown in Equation 3.  
Ksq =
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Where Ksq is the semiquinone formation constant, ([sq]/[AidB])max is the maximum proportion of 
semiquinone formed, and Em
ox/sq
 and Em
sq/red
 are the one-electron reduction potentials of flavin. Since 
Em
sq/red
 has already been measured (–258 mV), the oxidized to semiquinone reduction potential  
was calculated, Em
ox/sq
 = −103 ± 10 mV. The midpoint potential for the two-electron reduction of  
AidB (Em
ox/red
) was also calculated from the average of Em
ox/sq
 and Em
sq/red
, Em
ox/red
 = −181 mV. 
Figure 3. Maximum proportion of semiquinone formed by AidB during reduction is 
determined by plotting absorbance values at 365 nm vs. 440 nm. The linear fits,  
shown as dashed lines, are used to determine the theoretical absorbance of complete  
semiquinone formation. 
 
2.2. Effect of IVCoA on Reduction Potential 
To better understand possible AidB dehydrogenase activity, we studied the redox properties as a 
function of IVCoA concentration. As expected, anaerobic incubation of IVCoA with AidB did not 
result in any reduction or alteration of the FAD absorption spectrum [17]. Reduction in the presence of 
saturating IVCoA concentrations significantly shifted both potentials in the negative direction to  
Em
ox/sq
 = −148 ± 10 mV and Em
sq/red
 = −297 mV ± 5 mV, a −42 mV change in Em. The amount of 
semiquinone formed was unaffected by the presence of IVCoA. The dependence of Em on [IVCoA] 
was used to determine the apparent dissociation constant (Kd
app
, Figure 4). The shift in reduction 
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potential was fit to a simple two-state binding model (Equation 4) for determining the  
dissociation constant.  
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Where Em is the midpoint potential at a given IVCoA concentration, Em
0
 is the midpoint potential 
without IVCoA, Em
max
 is the reduction potential at saturating concentrations of IVCoA, and Kd
app
 is the 
apparent dissociation constant. The determined Kd
app
 = 87 ± 27 μM represents binding of IVCoA to 
oxidized, semiquinone, and reduced forms of the enzyme. Binding of IVCoA causes a negative shift in 
reduction potential, which indicates a preference for and stabilization of oxidized AidB.  
Figure 4. Midpoint reduction potential (Em) of AidB lowers as a function of isovaleryl-CoA 
(IVCoA) concentration. The dotted line is the fit to equation 4 to determine Kd
app
. 
 
2.3. Ionic Strength Dependent Reduction Potentials 
It has been shown that AidB binds DNA using its C-terminal positively charged domain [18]. Due 
to the electrostatic nature of this interaction, it is highly dependent on ionic strength [17,18,21]. To 
measure changes in redox properties when AidB is exposed to DNA, the reduction potential had to 
first be characterized without DNA in the presence of 100 mM NaCl, which is a concentration of NaCl 
where AidB is known to have a high affinity for DNA [17,21]. Compared to 300 mM NaCl in  
earlier measurements, lowering the NaCl concentration to 100 mM shifts the reduction potential to 
significantly more negative values. At 100 mM NaCl, reduction potentials are: Em
ox/sq
 = −160 ± 6 mV 
and Em
sq/red
 = −315 ± 4 mV, with no change in the amount of semiquinone formed. Further studies at a 
broader NaCl range showed that below 300 mM NaCl, the AidB reduction potential depends strongly 
on NaCl concentration (Figure 5). 
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Figure 5. Midpoint reduction potential (Em) of AidB at various NaCl concentrations. 
 
2.4. Effect of DNA on Reduction Potential 
After determining the effects of ionic strength on AidB redox properties, we could determine the 
impact of DNA on the observed reduction potentials. AidB binds several forms of DNA, ranging from 
small oligomers (25 bp) [18] to entire plasmids such as pUC19 [17]. To determine if DNA binding 
regulates AidB’s redox properties, we measured reduction potentials under saturating DNA 
concentrations. Two forms of DNA were used for binding during reductions: pUC19 and a double 
stranded 28 bp oligomer containing the UP element in addition to the −35 box of the rrnB P1 promoter 
(5'-GAAAATTATTTTAAATTTCCTCTTGTCA-3'). The sequence for the 28-mer was chosen 
because AidB offers above average protection from damage to this DNA segment [19]. Measurements 
with pUC19 included 500 ng/mL DNA (322 bp per AidB tetramer), and measurements with the  
28-mer included 214 ng/mL DNA (154 bp per AidB tetramer). Reduction potential measurements 
were completed in lowered ionic strength solutions (100 mM NaCl) as described above. Both plasmid 
and the 28-mer resulted in a positive shift of the reduction potentials of AidB. Addition of pUC19 to 
the reduction of AidB at 100 mM NaCl shifted the potentials positively Em
ox/sq
 = −121 ± 11 mV,  
Em
sq/red
 = −274 ± 5 mV, with no change in the yield of the AidB semiquinone. Similarly, the 28-mer 
shifted the potentials positively Em
ox/sq
 = −129 ± 11 mV and Em
sq/red
= −282 ± 5 mV, also with no 
change in the amount of semiquinone. 
2.5. AidB-ETF Docking Model 
If an ideal substrate for the AidB reductive half reaction exists, a mechanism would need to be in 
place to allow for reoxidation of the flavin cofactor. For ACADs such as medium-chain acyl-coenzyme 
A dehydrogenase (MCAD) and IVD, an electron transfer flavoprotein (ETF) accepts the electrons 
from the reduced flavin of the ACAD and further transfers them to the respiratory chain [25]. 
Structures of ETFs from Paracoccus denitrificans [26] and human [27] are known, and the 
determinants of binding to ACADs and other partner proteins are well-characterized on the basis of 
crystal structures of the human MCAD-ETF complex and a complex of Methylophilus methylotrophus 
ETF with trimethylamine dehydrogenase (TMADH) [28,29]. To examine whether AidB could interact 
with an ETF, we generated models of a complex between AidB and the human ETF using the known 
crystal structure of the MCAD-ETF complex (Figure 6). 
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Figure 6. Model of the docking between AidB and the human ETF. (A) Side-by-side views 
of the AidB-ETF docking model (left) and the MCAD-ETF complex structure (right), 
shown in the same orientation. For the docking, the crystal structure of AidB (PDB ID: 
3U33 [21]) was superimposed onto the MCAD-ETF complex structure (PDB ID: 1T9G [29]). 
All structures are shown in ribbon representation, with the ETF in red, AidB protomers in 
yellow and orange, and MCAD protomers in dark and light green. Only one dimer is 
shown both for the AidB tetramer and the MCAD tetramer, the second dimer is omitted for 
clarity in both cases. Transparent surfaces are shown around all proteins in red (ETF), 
yellow (AidB) and green (MCAD). Bound FAD-cofactors of AidB and MCAD are shown 
in ball-and-stick representation with carbon atoms in light green and orange, respectively. 
The ETF recognition loop is shown in purple and interacting hydrophobic residues of AidB 
and MCAD are shown as orange and green spheres, respectively; (B) Wall-eyed stereo 
view of the ETF recognition loop interactions. The docking was generated in the same 
fashion as in (A). The recognition loop is shown in purple ribbons, with Leu195 shown as 
sticks. MCAD residues from the MCAD-ETF complex structure that are interacting with 
the recognition loop are shown with pale green carbons. AidB residues near the putative 
location of ETF Leu195 are shown with yellow carbons. The axes of the recognition loop 
helix, MCAD helix C, and the corresponding AidB helix are shown and colored by dipole 
moment from blue (positive) to red (negative); (C) Multiple sequence alignment of ETFs 
from different organisms. The residue that inserts into the hydrophobic pocket of partner 
proteins is highlighted in yellow. Other conserved residues are shown in blue.  
Ec, E. coli (protein YdiQ); Bs, Bacillus subtillis; Mme, Methylophilus methylotrophus;  
Mb, Mycobacterium bovus; Pd, Paracoccus denitrificans; Ca, Clostridium acetobutylicum; 
At, Arabidopsis thaliana; Hs, Homo sapiens; Mmu, Mus musculus; Bb, Bos bovus. 
A 
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Figure 6. Cont. 
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When considering docking of the ETF to an AidB tetramer, which is the predominant state of AidB 
in solution [21], one dimeric unit of AidB is unfavorably close to the human ETF FAD-binding 
domain (not shown). However, the implications of this clash are difficult to assess, as the ETF  
FAD-binding domain is thought to be flexible both when the ETF is free in solution and in complex 
with its partner proteins [25,29–31]. In terms of docking with an AidB dimer, here the overall shape 
complementarity is favorable and similar to the human MCAD-ETF complex (Figure 6A) and the 
bacterial TMADH-ETF complex (not shown). Critical determinants for efficient electron transfer, 
however, are missing. In particular, both MCAD and TMADH present a hydrophobic pocket to the 
ETF recognition loop (residues 191–200, human numbering), which inserts a conserved hydrophobic 
residue (Leu195, human numbering) into this pocket (Figures 6A, 6B) [28,29]. Mutation of Leu195 or 
proteolytic removal of the recognition loop abolishes electron transfer between the ETF and its partner 
proteins, and mutational studies have furthermore demonstrated that the size of the hydrophobic pocket 
is also critical for efficient electron transfer [28,29]. Notably, even though MCAD and TMADH bind 
to the ETF in the same manner, they share no structural homology with each other, suggesting that the 
ETF uses the same binding mode for a range of structurally dissimilar partner proteins. While AidB 
contains a number of hydrophobic residues in the corresponding region, including Trp38, Phe42, and 
Leu103, the guanidinium moiety of AidB Arg120 would be pointed directly at the hydrophobic residue 
inserted by the ETF, providing an unfavorable interaction (Figure 6B). Arg120 is stabilized in this 
position by interaction with AidB Asp39 (not shown). Furthermore, helix C in AidB (residues 88–98) 
is tilted by 18° and appears unable to achieve the ideal alignment of the corresponding helix in MCAD 
(residues 50–60) with the ETF recognition loop helix, which is thought to stabilize the MCAD-ETF 
complex [28,29] (Figure 6B). Although the AidB helix could adopt a more favorable position upon 
binding of the ETF, no change is observed for MCAD upon ETF binding [29,32].  
The docking was carried out with the human ETF, but the critical residues are conserved in the  
M. methylotrophus ETF and the E. coli ETF (Figure 6C). In particular, Leu195 is Met, which can 
likely insert into the hydrophobic pocket in the same mode, and the hydrophobic Ile is found in 
position 191. In addition, I/L186, N187, P189, R190, and S/T194, which are thought to be important to 
stabilize the recognition loop structure, are conserved. A homology model of the E. coli ETF 
furthermore indicates that the E. coli ETF likely has the same conserved structure (not shown). 
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3. Discussion 
In this work, we have characterized the thermodynamic redox properties of AidB for the first time. 
We report the two one-electron reduction potentials for flavin bound to AidB, oxidized to semiquinone 
and semiquinone to reduced. Although this is the first characterization of AidB reduction potentials, 
the closely related ACAD family has been extensively studied [33]. A comparison of the AidB 
electrochemical properties reported here and those of homologous ACAD enzymes reveals both 
intriguing similarities and differences.  
The two-electron midpoint potential we have measured for AidB (Em
ox/red
 = −181 mV) is at the 
lower end of the −60 to −180 mV range reported for the two-electron reduction of ACAD enzymes at 
neutral pH values [33–38]. We also find that AidB stabilizes a large amount (92%) of the anionic 
semiquinone intermediate, a result that agrees with the reported single electron reduction of AidB 
using photoreduction methods [17]. In contrast, ACADs typically yield 0%–20% semiquinone. 
Stabilization of 0%–20% semiquinone intermediate indicates that the second one-electron reduction of 
the ACAD flavin is more thermodynamically favorable than the first, as denoted by a higher reduction 
potential. This coupling is essential because it allows for the two-electron transfer required during the 
dehydrogenation mechanism of ACADs. Since AidB stabilizes 92% of the anionic semiquinone, the 
second one-electron reduction step is less thermodynamically favorable by −155 mV. Uncoupling of 
the two one-electron reduction steps to this extent significantly hinders the ability for AidB to extract 
two electrons as needed for ACAD activity. Thus, these data indicate that AidB could be involved in a 
different type of reaction, possibly involving one-electron transfers. 
In general, the reduction potentials of ACADs are more negative than the reduction potentials of 
their acyl-CoA substrates, which themselves have reduction potentials of roughly −40 mV [34]. To 
generate a thermodynamically favorable electron transfer from acyl-CoA to flavin, a large positive 
shift in the reduction potential of the bound flavin occurs when ACAD enzymes bind their biological 
substrates. This trend has been demonstrated in several ACADs from various sources, including  
short-chain acyl-CoA dehydrogenase (SCAD) from Megasphaera elsdenii (MeSCAD) [35–37], 
MCAD from pig kidney (pMCAD) [34,38], glutaryl-CoA dehydrogenase from Paracoccus 
denitrificans (PdGCD) [39], and human SCAD (hSCAD) [40] (Table 1). This substrate-dependent 
redox modulation, which facilitates dehydrogenation of the appropriate substrate, is a distinctive redox 
property of ACADs. Such modulation could be an important feature retained in AidB that is necessary 
for catalytic activity.  
We therefore measured the AidB reduction potentials in the presence of the putative substrates 
IVCoA and DNA. Notably, IVCoA induces a decrease in the AidB flavin reduction potentials, which 
expands the overall difference in reduction potential between the acyl-CoA and the flavin. A similar 
phenomenon of decreasing flavin reduction potentials has been observed for ACADs in the presence  
of non-natural substrates (Table 1) [35,36,38–40]. With hSCAD, for example, the ideal ligand,  
butyryl-CoA, shifts the reduction potential positively, while longer acyl chains lead to a negative  
shift [40]. Similar down-regulating behavior observed in AidB with IVCoA could indicate that an 
increase of the AidB flavin reduction potential takes place upon binding to its as yet unknown 
biological substrate, and that once again IVCoA is not the relevant substrate.  
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Table 1. Comparison of AidB with previously reported ACAD reduction potentials in mV. 
Measurements are listed for free enzymes as well as proteins in the presence of substrate (S), 
product (P), or non-optimal substrates described in the text or corresponding references. 
Protein Em
ox/sq
 Em
sq/red
 Em
ox/red
 % sq pH Radical Ref. 
AidB (300 mM NaCl) −103 −258 −181 92 8.0 anionic - 
AidB + IVCoA (300 mM NaCl) −148 −297 −222 91 8.0 anionic - 
AidB (100 mM NaCl) −160 −315 −237 92 8.0 anionic - 
AidB + pUC19 (100 mM NaCl) −121 −274 −197 92 8.0 anionic - 
AidB + 28-mer (100 mM NaCl) −129 −282 −205 92 8.0 anionic - 
MeSCAD - - −79 5 7.0 neutral [35] 
MeSCAD + S/P - - −19 0 7.0 - [37] 
MeSCAD + Butyl-CoA - - −79 0 6.9 - [36] 
MeSCAD + Acetoacetyl-CoA - - −180 0 7.0 - [35] 
PdGCD - - −85 0 6.4 - [39] 
PdGCD + S/P - - 30 5 6.4 anionic [39] 
PdGCD + Acetoacetyl-CoA −154 † −104 † −129 15 6.4 neutral [39] 
pMCAD −166 −129 −136 20 7.6 neutral [38] 
pMCAD + S/P - - −26 0 7.6 - [34] 
pMCAD + Butyl-CoA −189 † −155 † −172 20 7.6 neutral [38] 
hSCAD * - - −141 ≤5 7.6 - [40] 
hSCAD * + Butyryl-CoA - - −103 ≤5 7.6 - [40] 
hSCAD * + Octanoyl-CoA - - −161 ≤5 7.6 - [40] 
* hSCAD reduction potentials reported for inactivated mutant enzyme. † Values calculated from reported Em 
and percent semiquinone values. 
The observed reduction potential modulations upon IVCoA binding are unusual because there is no 
obvious change in the FAD absorption spectrum upon IVCoA binding. Thus, the interactions between 
the acyl-CoA and AidB do not seem to have major structural impact on the FAD isoalloxazine ring. 
This finding is also consistent with semiquinone yield remaining constant. Unfortunately, we could not 
characterize the interaction between AidB and IVCoA using isothermal titration calorimetry due to the 
instability of AidB in the time course of the experiment. However, by taking advantage of the AidB 
FAD reduction potential shift upon IVCoA binding, we determined the apparent dissociation  
constant between AidB and IVCoA to be 87 μM. This binding affinity for IVCoA is, not surprisingly, 
weak compared to those of ACADs for their biologically relevant substrates (see for example  
references [40–44] and references therein). The reduced affinity for IVCoA, however, does not fully 
explain why the AidB dehydrogenase activity is so weak. Instead, our results suggest that unfavorable 
redox thermodynamics are the major factors limiting catalysis. 
When DNA binds to AidB, we observed an up-shift of AidB flavin reduction potentials. This  
up-shift was observed with both plasmid and a double stranded 28-mer to which AidB preferentially 
binds in vivo [19], with the caveat that strong binding occurs at low ionic strengths which themselves 
have a drastic negative effect on reduction potential. The redox dependence on ionic strength 
marginalizes our observed regulation of reduction potential by DNA, as it is more likely that simple 
counter-ions are maintaining high reduction potentials in vivo. When DNA is present with 100 mM 
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NaCl during in vitro experiments, some of these counter-ions are likely provided by the charged 
phosphate backbone, allowing for only a modest shift in reduction potential when compared to the 
effects of 300 mM NaCl. These data suggest that the presence of DNA does not have a strong effect on 
the flavin reactivity in AidB, a hypothesis that agrees with in vivo studies where the DNA-binding 
domain is removed without affecting AidB’s detoxification activity [19]. 
For AidB to catalyze a redox reaction, a mechanism would have to be in place to restore the 
oxidation state of the flavin cofactor, either reoxidizing reduced flavin after oxidation of a substrate by 
AidB, or vice versa. For ACADs, reoxidation of flavin occurs by two one-electron transfers to two 
ETFs [33,45]. ETFs are thought to form transient complexes with their different partner proteins, 
accepting electrons from different redox cofactors through reduction of their own flavin cofactor [25]. 
Efficient complex formation is dependent on docking of the recognition loop of the ETF to a 
hydrophobic pocket on the surface of its partner protein [28,29]. In our docking experiments, we find 
that this interaction is not conserved for AidB. Although modeling experiments cannot rule out an 
AidB-ETF interaction, the absence of the structural motifs in AidB thought to be crucial for this 
protein:protein interaction suggests that ETF is not a physiological electron acceptor for AidB. Thus, 
both the reductive and the oxidative half reactions of the AidB flavin appear to be different from the 
ACAD family. Since the chemistry of AidB has not been established, we do not know if flavin needs 
to be reoxidized, like ACADs by ETF as described above, or rereduced to catalyze its reaction. In this 
light, Mulrooney et al. investigated flavin reduction in AidB by flavodoxin (FldA) [20]. Flavodoxin is 
reported to bind to AidB and reduce flavin in AidB to the semiquinone state, but at a slow rate [20]. 
However, our electrochemical results demonstrate that the midpoint potentials of AidB  
(Em
ox/sq
 = −103 mV, Em
sq/red
 = −258 mV) and FldAox/sq (–285 mV, [46]) are poised for effective 
electron transfer. Despite an appropriate reduction potential and binding affinity [20] the reduction of 
AidB by flavodoxin is sluggish, possibly due to the fact that the flavin in AidB is far from any 
accessible surface. The physiological relevance, if any, of this slow reduction by flavodoxin remains to  
be determined.  
Overall, AidB exhibits major differences to its ACAD sequence homologs in terms of the redox 
chemistry of the associated flavin cofactor. These differences could be important for the divergent role 
of AidB. While ACADs perform oxidations of acyl chains, AidB has an important function in the 
bacterial adaptive response to alkylating agents. In particular, recent studies have demonstrated that 
AidB exerts a general protective effect on DNA against alkylation [19]. The protection itself does not 
rely on the DNA-binding domain, as demonstrated by studies with a truncated mutant lacking the 
DNA-binding domain. In agreement with these results, we do not observe a change in the AidB 
reduction potential in the presence or absence of DNA. The DNA-binding capacity of AidB instead 
appears to be important to localize AidB to so-called UP elements, resulting in increased protection of 
the crucial downstream genes such as ribosomal RNA genes, tRNA genes, and DNA repair genes [19]. 
Our electrochemical studies confirm that AidB is indeed poised for redox chemistry. The 
accumulated data point toward a function of AidB in the detoxification of alkylating agents, either by 
oxidation or by reduction, to prevent, rather than repair, DNA damage. Such a reaction could occur 
through one-electron chemistry that AidB can engage in, as indicated by the high degree of 
semiquinone stabilization. Possible substrates for AidB could be alkylating agents such as MNNG and 
MMS, although AidB was shown not to react with MNNG [20], or their metabolically activated forms, 
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the exact natures of which are still unknown. Other hypotheses, such as direct DNA repair or a distinct 
ACAD activity, seem improbable at this point. The major task at hand now is the identification of 
AidB’s substrate, which will likely reveal the function of this enigmatic protein. 
4. Experimental Section  
4.1. Redox Potentiometry 
Reduction potentials of the AidB FAD cofactor were measured using the xanthine/xanthine oxidase 
system described by Massey [47]. All measurements were conducted under anaerobic conditions 
(100% N2) in an MBraun glovebox using a S. I. Photonics 400 series spectrophotometer. E. coli AidB 
was prepared as described elsewhere [21]. The solution contained ~10 μM freshly purified protein in 
buffer (50 mM Tris, pH 8.0, 1 mM ethylenediaminetetraacetic acid, 300 mM NaCl, 10% (v/v) glycerol, 
5 mM β-mercaptoethanol, 3–5 μM phenosafranine (PS), 1 μM benzyl viologen, 1 μM methyl viologen, 
and 350 μM xanthine). PS was added as the reference dye, and benzyl viologen and methyl viologen 
were included to ensure rapid equilibrium, but at small concentrations that would not perturb the 
spectra. Reduction of the mixture was initiated by the addition of 500 nM xanthine oxidase and full 
spectra were collected every 3–5 min until completion. When IVCoA or DNA was included, time was 
allowed for equilibration before the addition of xanthine oxidase. AidB absorbance was isosbestic at 
555 nm so it could be used to monitor concentrations of oxidized and reduced PS. AidB reduction was 
monitored at the PS isosbestic point, 406 nm. Oxidized (ox) to reduced (red) absorbance transitions for 
PS and AidB were plotted as log ([ox]/[red])PS vs. log ([ox]/[red])AidB. From this plot, AidB reduction 
potentials (Em) were calculated based on the known reduction potential of PS, −283 mV at pH 8 [48]. 
All potentials reported are versus the standard hydrogen electrode. 
The maximum amount of semiquinone intermediate (sq) formed during the experiment was 
determined as previously described [47]. The reduction of AidB was monitored at two wavelengths 
representing the oxidized (440 nm) and semiquinone (365 nm) forms. The plot of these two 
wavelengths during the course of reduction has two linear regions. The intercept of these linear fits is 
determined and the y-coordinate of this intercept corresponds to the theoretical absorbance  
of semiquinone at 365 nm if 100% semiquinone was formed. The experimental maximum  
semiquinone absorbance can then be used to determine the maximum proportion of semiquinone  
formed, ([sq]/[AidB])max. 
4.2. Structural Modeling of Electron Transfer Flavoprotein Docking 
To generate the docking model of AidB and human electron transfer flavoprotein (ETF), a dimer or 
tetramer of AidB (PDB ID: 3U33 [21]) was aligned with chain D of MCAD from the MCAD-ETF 
complex structure (PDB ID: 1T9G [29]) by a sequence-independent structure-based alignment in 
PyMOL [49]. Figures of the docking were generated in PyMOL [49]. 
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5. Conclusions  
We have characterized the redox properties of the AidB FAD cofactor, whose reduction potentials 
are well within the known flavin reduction potential range for biological chemistries. Like ACADs, the 
binding of CoA thioesters alters the redox properties of the flavin, but unlike ACADs, the semiquinone 
form of the flavin is highly stabilized. The reduction potentials of AidB are affected more dramatically 
by ionic strength than by the presence of DNA, suggesting that the adaptation of the ACAD-fold for 
DNA binding, which is observed in the AidB protein, is largely inconsequential in terms of redox 
chemistry. While flavodoxin can reduce AidB slowly, docking studies suggest that unlike members of 
the ACAD family, ETF would not be a good electron acceptor for AidB. Overall, while there are 
structural and redox similarities to the ACAD family of enzymes, AidB is not poised to carry out a 
reaction by the typical ACAD mechanism. Since the reduction potentials of AidB are in a biologically 
relevant range, our work is consistent with AidB being a redox active enzyme. However,  
the mechanism that AidB employs will likely have diverged from that engaged by ACAD  
family members. 
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